CAS 2283348-97-8

Lirentelimab

CAS : 2283348-97-8

Lirentelimab (AK002) is a humanized anti-Siglec-8 antibody that induces IL-5-activated apoptosis in eosinophils and inhibits IL-5-mediated mast cell activation.

Degré de pureté : 97.7% (SDS-PAGE); 99.7% (SEC-HPLC) - 97.7% (SDS-PAGE); 99.7% (SEC-HPLC)

Couleur et forme : Liquid

Masse moléculaire : 144.55 kDa

Ref: TM-T76869